Mycobacterial diseases are a group of infectious illnesses caused by bacteria belonging to the genus Mycobacterium. Notable among these diseases is tuberculosis (TB), caused by Mycobacterium tuberculosis, and leprosy, caused by Mycobacterium leprae. Tuberculosis primarily affects the lungs and can be transmitted through the air when an infected person coughs or sneezes. It remains a significant global health concern, with symptoms ranging from persistent cough and weight loss to fatigue and fever. Treatment involves a course of antibiotics, and efforts are ongoing to enhance diagnostics and access to care. Leprosy, on the other hand, primarily affects the skin and peripheral nerves. While less common today, pockets of the disease persist in some regions. Early diagnosis and treatment with multidrug therapy are crucial to prevent complications and disabilities associated with leprosy. Both TB and leprosy are communicable diseases, and their control involves strategies such as timely diagnosis, effective treatment, and public health measures to prevent the spread of the bacteria. Vaccines, like the Bacillus Calmette-Guérin (BCG) vaccine for TB, are used to reduce the incidence of these diseases, especially in regions where they are endemic. Mycobacterial diseases highlight the importance of comprehensive public health efforts, including education, vaccination, and accessible healthcare, in managing and preventing the transmission of these communicable diseases. Ongoing research and advancements in diagnostics and treatment continue to contribute to the global efforts to control and eliminate mycobacterial diseases.
Title : The impact of AI on the future of public health and preventative healthcare
David John Wortley, World Lifestyle Medicine Education Services, United Kingdom
Title : Change your genes – change your life: Epigenetics of longevity
Kenneth R Pelletier, University of California, United States
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model to secure the human healthcare, wellness and biosafety through the view of public health, network-driven healthcare services and lifestyle management
Sergey Suchkov, 1N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Moscow, Russia, Russian Federation
Title : Psychoeducation programs to address post-traumatic stress injuries and mental health in public safety and frontline health care workers
Gregory S Anderson, Thompson Rivers University, Canada
Title : Multi-dimensional scaling of healthcare system profiles and pandemic outcomes in Cuba, Spain, Italy, and Germany
Giuseppe Orlando, University of Bari Aldo Moro, Italy